PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
150.33%
Some net income increase while CRK is negative at -263.72%. John Neff would see a short-term edge over the struggling competitor.
-23.19%
Both reduce yoy D&A, with CRK at -73.84%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-66.67%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
33.33%
SBC growth while CRK is negative at -2.31%. John Neff would see competitor possibly controlling share issuance more tightly.
-272.73%
Both reduce yoy usage, with CRK at -142.73%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-16.08%
AR is negative yoy while CRK is 84.31%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-154.55%
Both reduce yoy usage, with CRK at -92.42%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-48.72%
Negative yoy while CRK is 167.86%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
15.02%
Operating cash flow growth above 1.5x CRK's 4.05%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-2.04%
Negative yoy CapEx while CRK is 6.39%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-95.00%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
122.58%
Growth well above CRK's 111.17%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
28.19%
Investing outflow well above CRK's 7.44%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-590.00%
Both yoy lines negative, with CRK at -49.80%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.